FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · IEX Real-Time Price · USD
4.500
-0.490 (-9.82%)
At close: Jul 19, 2024, 4:00 PM
4.460
-0.040 (-0.89%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $160.74 million as of July 22, 2024.
Market Cap
160.74M
Enterprise Value
154.69M
1-Year Change
n/a
Ranking
Category
Stock Price
$4.50
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $821.50M to $160.74M, a decrease of -80.43%. That is a compound annual growth rate of -96.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 147.20M | -82.08% |
| Jan 31, 2024 | 821.50M | - |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MediWound | 176.02M |
| Metagenomi | 174.96M |
| Acumen Pharmaceuticals | 172.43M |
| Puma Biotechnology | 172.21M |
| Repare Therapeutics | 171.48M |
| Rani Therapeutics Holdings | 169.91M |
| OrganiGram Holdings | 169.53M |
| Rigel Pharmaceuticals | 167.68M |